Accueil › Leucémie aiguë myéloïde › Michigan › Ann Arbor
Essais cliniques pour Leucémie aiguë myéloïde à Ann Arbor, MI
17 études pour Leucémie aiguë myéloïde recherchent des participants dans et autour de Ann Arbor (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · à 7 mi
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · à 15 mi
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · à 18 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · à 7 mi
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · à 7 mi
- et 4 autres
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · à 7 mi
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · à 15 mi
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · à 18 mi
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Recrutement en coursPhase 3
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · à 7 mi
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Recrutement en coursPhase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · à 7 mi
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · à 15 mi
- et 1 autres
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Recrutement en coursPhase 1
- C S Mott Children's Hospital, Ann Arbor
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · à 7 mi
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · à 15 mi
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · à 18 mi
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · à 7 mi
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · à 15 mi
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · à 18 mi
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · à 7 mi
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · à 15 mi
- et 1 autres
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Recrutement en coursPhase 3
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Recrutement en coursPhase 3
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Recrutement en coursPhase 1/2
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Recrutement en coursPhase 3
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Recrutement en coursPhase 3
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recrutement en coursÉtude observationnelle
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Recrutement en coursPhase 1
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Recrutement en coursPhase 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Essais pour Leucémie aiguë myéloïde dans d'autres villes
- Houston, TX85 études
- New York City, NY51 études
- Boston, MA44 études
- Baldwin Park, CA40 études
- Seattle, WA40 études
- Columbus, OH35 études
- Philadelphia, PA34 études
- Durham, NC33 études
- Atlanta, GA30 études
- Tampa, FL29 études
- Chicago, IL26 études
- Portland, OR25 études
Autres études à Ann Arbor
- Cancer de la prostate27 études
- Cancer du sein26 études
- Cancer du poumon non à petites cellules26 études
- Cancer (tous types)25 études
- Cancer colorectal23 études
- Cancer du poumon23 études
- Insuffisance cardiaque22 études
- Maladie cardiovasculaire16 études
- Cancer du pancréas14 études
- Mélanome12 études
- Cancer du rein (carcinome à cellules rénales)12 études
- Carcinome épidermoïde de la tête et du cou12 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.